The discounts should be compared against the drugs’ “ultimate net price” rather than their indicated list price to gauge the ...

Imfinzi is the first immunotherapy approved for perioperative use to treat gastric and gastroesophageal junction cancers.

Tecvayli plus Darzalex led to an 83% boost to progression-free survival versus the current standard therapy in relapsed or ...

A coordinated national effort is emerging to bring alternatives to animal testing into routine preclinical use, backed by a ...

Previous mega blockbusters took years to reach their peak sales. Lilly’s tirzepatide franchise is on course to exceed them ...

The record-setting government shutdown was just the latest blow to the U.S. biopharma industry. When science funding becomes ...

Richard Pazdur, the new director of the Center for Drug Evaluation and Research, raised concerns amid the rollout of several ...

At one point in merger negotiations with Novartis, Avidity CEO Sarah Boyce and her team walked, cutting off access to a data ...

The FDA approved an intrathecal form of Novartis’ spinal muscular atrophy gene therapy Zolgensma on Monday, broadening access ...

Novo Nordisk’s amycretin showed no weight-loss plateau over 36 weeks in patients with type 2 diabetes, suggesting its efficacy could become even stronger with longer follow-up, according to analysts ...

Alicia Jackson formerly served as deputy director of the Biological Technologies Office at the Defense Advanced Research ...

Experts suggest the FDA’s Advanced Manufacturing Technologies designation could be a lifeline for improving production ...